A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/1999
12/21/1999	US6005003 Osteoporosis treatment
12/21/1999	US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999	US6004971 Pentacyclic compounds, intermediates, processes, compositions, and methods
12/21/1999	US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999	US6004299 Injection vessel and solution-enclosed injection vessel in use thereof
12/16/1999	WO1999064565A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
12/16/1999	WO1999064426A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999	WO1999064423A1 Furopyridine derivatives and their therapeutical use
12/16/1999	WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/16/1999	WO1999064414A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	WO1999064406A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999	WO1999064400A1 INHIBITORS OF p38
12/16/1999	WO1999064399A1 Protease inhibitors
12/16/1999	WO1999064039A1 Bradykinin antagonists
12/16/1999	WO1999064021A1 hCEPR RECEPTOR
12/16/1999	WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999	WO1999063974A2 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
12/16/1999	WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999	WO1998024902A8 Adaptor protein frs2 and related products and methods
12/16/1999	CA2768882A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768841A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768828A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768773A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2768682A1 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
12/16/1999	CA2680649A1 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
12/16/1999	CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999	CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999	CA2334652A1 Protease inhibitors
12/16/1999	CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999	CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999	CA2333551A1 A process for the preparation of macrocyclic metalloprotease inhibitors
12/16/1999	CA2319730A1 Bradykinin antagonists
12/15/1999	EP0963200A2 Methods and compositions for inhibition of angiogenesis
12/15/1999	CN1238691A Liquid alendronate preparation
12/15/1999	CN1238689A Vitronectin receptor antagonists
12/15/1999	CN1238209A Medicinal composition for treating hyperosteogeny and preparing method thereof
12/14/1999	US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999	US6001855 Thiazole derivatives
12/14/1999	US6001651 Antisense modulation of LFA-3
12/14/1999	US6001623 Polynucleotide sequence coding a human enzymatic polypeptide; for developing treatments and diagnostic assays for disease
12/14/1999	US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999	US6001389 Compositions containing biologically active silicon
12/14/1999	CA2181150C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
12/14/1999	CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/09/1999	WO1999062883A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors
12/09/1999	WO1999062875A1 Nitric oxide synthase inhibitors
12/09/1999	WO1999062543A1 Composition based on pentoxifylline and anticytokin
12/09/1999	WO1999062540A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	WO1999062538A1 Alpha-keto oxadiazoles as serine protease inhibitors
12/09/1999	WO1999062528A1 Treatment of arthritis and other similar conditions
12/09/1999	WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999	WO1999062525A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999	WO1999062507A1 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
12/09/1999	WO1999062505A2 Method for treating neurodegenerative disorders
12/09/1999	WO1999051262A3 Use of igfi for treating articular cartilage disorders
12/09/1999	WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999	CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999	CA2333726A1 Compositions comprising methotrexate and pentostatin for treating rheumatoid arthritis
12/09/1999	CA2333315A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/08/1999	EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999	EP0962457A1 Piperidones as tachykinin antagonists
12/08/1999	EP0961779A1 SUBSTITUTED AMINO BICYCLIC-$g(b)-LACTAM PENAM AND CEPHAM DERIVATIVES AS CYSTEINE PROTEASE INHIBITORS
12/08/1999	EP0961775A2 Purine l-nucleosides, analogs and uses thereof
12/08/1999	EP0961618A1 Novel compounds
12/08/1999	EP0961613A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
12/08/1999	EP0643716B1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/08/1999	CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999	CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999	CN1237427A Adhesive plaster for curing prolapse of lumbar intervertebral disk
12/07/1999	US5998473 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester derivatives
12/07/1999	US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998443 Phosphorous containing benzothiophenes for treating estrogen deficiency
12/07/1999	US5998442 Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia
12/07/1999	US5998402 Osteoporosis; cardiovascular disorders; anticancer agents;postmemopause therapy
12/07/1999	US5998401 Naphthyl compounds, intermediates, compositions, and methods
12/07/1999	US5998390 Combination of bisphosphonate and tetracycline
12/07/1999	US5998369 Treatment of osteoporosis
12/07/1999	US5998137 To assess predisposition or susceptibility to a number of diseases: osteoporosis, atherosclerosis, cancer and immune disorders.
12/07/1999	CA2180717C Use of phosphorus derivatives of alkaloids for treating endocrinopathies
12/02/1999	WO1999061611A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/02/1999	WO1999061593A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
12/02/1999	WO1999061590A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src
12/02/1999	WO1999061476A1 Peptide antiangiogenic drugs
12/02/1999	WO1999061471A2 Human transmembrane proteins
12/02/1999	WO1999061466A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy
12/02/1999	WO1999061440A1 Novel substituted imidazole compounds
12/02/1999	WO1999061437A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999	WO1999061426A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999	WO1999061422A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
12/02/1999	WO1999061418A2 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
12/02/1999	WO1999061412A1 Hydroxamic acid derivatives and medicinal utilization thereof
12/02/1999	WO1999061398A2 24-hydroxyvitamin d, analogs and uses thereof
12/02/1999	WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999	WO1999061024A1 Peripheral benzodiazepine receptor ligands
12/02/1999	WO1999019354A9 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
12/02/1999	CA2333270A1 1.alpha.-hydroxy-25-ene-vitamin d, analogs and uses thereof
12/02/1999	CA2333157A1 Novel substituted imidazole compounds
12/02/1999	CA2332946A1 Hydroxamic acid derivative and pharmaceutical use thereof

1 ... 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 ... 820